SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Scienture Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.92−0.44 (-13.10%)

Close on Oct 19, 2026

Market cap: $115.68M
P/E (TTM): –
Dividend yield: –

Scienture Holdings, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Depreciation & Amortization	0.49	–	–	–	–	–	–	–	–	–	–	–	–
Stock-Based Compensation	2.07	0.03	0.03	0.08	0.06	0.45	0.18	–	–	–	0	0.58	–
Change in Accounts Receivable	-0.72	-0.01	-0.29	0.37	-0.79	-0.02	-0.37	0.00	-0.02	0.06	0.04	0.26	-0.01
Change in Inventory	-0.21	0.00	4.23	-0.05	0.83	-2.42	0.02	0.00	–	–	0.26	0.00	0.04
Change in Accounts Payable	-1.57	0.45	1.61	0.20	0.22	-0.03	-0.15	0.10	-0.10	0.02	-0.07	0.13	0.05
Change in Unearned Revenue	–	–	–	–	-0.01	0.01	–	–	–	–	–	–	–
Operating Cash Flow	-13	-14	-2.23	-0.20	-2.57	-2.21	0.14	0.27	0.17	-0.50	0.09	-1.06	-0.84
Capital Expenditures	–	-0.01	–	–	-0.02	-0.04	–	–	–	–	–	–	-0.01
Acquisitions	–	–	-0.34	–	–	–	–	–	–	–	–	–	–
Sale of Property, Plant & Equipment	–	–	–	0.00	–	–	–	–	–	–	–	–	–
Investing Cash Flow	–	28	-0.28	0.00	-0.02	-0.04	-0.33	-0.27	0	-0.08	–	–	0.01
Dividends Paid	–	-15	–	–	–	–	–	–	–	–	–	–	–
Stock Issued	26	2.95	–	0.13	–	5.99	2.46	0.80	0.25	0.30	0	1.20	–
Debt Issued	–	–	–	–	–	–	–	–	–	–	0.95	0	–
Financing Cash Flow	20	-13	1.41	0.24	-0.21	5.30	2.19	0.68	0.00	0.62	1.36	1.69	0.94
Net Change in Cash	6.35	0.31	-1.09	-2.03	-2.80	3.05	2.00	0.69	0.17	-0.06	-0.62	0.62	0.08
Free Cash Flow	–	-14	–	–	-2.59	-2.25	–	–	–	–	–	–	-0.86
Income Taxes Paid	–	–	–	–	–	–	–	–	0	0	0	0	0
Interest Paid	–	–	0.73	0.34	0.03	0.03	0.10	0.04	0.07	0.02	0.00	0.00	0.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 166.9%
Operating margin: -9284.1%
Net margin: -8793.2%
Return on equity, FY2025: -55.6%

Financial strength

Current ratio: 3.04
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 270.6%

Valuation

P/E ratio: –
Price to sales: 268.02
Price to book: 1.80
Dividend yield: –